These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37804174)

  • 1. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
    O'Dowd EL; Tietzova I; Bartlett E; Devaraj A; Biederer J; Brambilla M; Brunelli A; Chorostowska J; Decaluwe H; Deruysscher D; De Wever W; Donoghue M; Fabre A; Gaga M; van Geffen W; Hardavella G; Kauczor HU; Kerpel-Fronius A; van Meerbeeck J; Nagavci B; Nestle U; Novoa N; Prosch H; Prokop M; Putora PM; Rawlinson J; Revel MP; Snoeckx A; Veronesi G; Vliegenthart R; Weckbach S; Blum TG; Baldwin DR
    Eur J Cardiothorac Surg; 2023 Oct; 64(4):. PubMed ID: 37804174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
    O'Dowd EL; Tietzova I; Bartlett E; Devaraj A; Biederer J; Brambilla M; Brunelli A; Chorostowska-Wynimko J; Decaluwe H; Deruysscher D; De Wever W; Donoghue M; Fabre A; Gaga M; van Geffen W; Hardavella G; Kauczor HU; Kerpel-Fronius A; van Meerbeeck J; Nagavci B; Nestle U; Novoa N; Prosch H; Prokop M; Putora PM; Rawlinson J; Revel MP; Snoeckx A; Veronesi G; Vliegenthart R; Weckbach S; Blum TG; Baldwin DR
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37802631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a Pan-European Technical Standard for a Comprehensive High-quality Lung Cancer CT Screening Program. An ERS Technical Standard.
    Baldwin D; O'Dowd E; Tietzova I; Kerpel-Fronius A; Heuvelmans M; Snoeckx A; Ashraf H; Kauczor HU; Nagavci B; Oudkerk M; Putora PM; Rzyman W; Veronesi G; Borondy-Kitts A; Gratacos AR; van Meerbeeck J; Blum TG
    Eur Respir J; 2023 May; ():. PubMed ID: 37202154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer." E.L. O'Dowd, I. Tietzova, E. Bartlett,
    Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38302184
    [No Abstract]   [Full Text] [Related]  

  • 5. ESR/ERS statement paper on lung cancer screening.
    Kauczor HU; Baird AM; Blum TG; Bonomo L; Bostantzoglou C; Burghuber O; Čepická B; Comanescu A; Couraud S; Devaraj A; Jespersen V; Morozov S; Agmon IN; Peled N; Powell P; Prosch H; Ravara S; Rawlinson J; Revel MP; Silva M; Snoeckx A; van Ginneken B; van Meerbeeck JP; Vardavas C; von Stackelberg O; Gaga M;
    Eur Radiol; 2020 Jun; 30(6):3277-3294. PubMed ID: 32052170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESR/ERS white paper on lung cancer screening.
    Kauczor HU; Bonomo L; Gaga M; Nackaerts K; Peled N; Prokop M; Remy-Jardin M; von Stackelberg O; Sculier JP; ;
    Eur Radiol; 2015 Sep; 25(9):2519-31. PubMed ID: 25929939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental renal tumours on low-dose CT lung cancer screening exams.
    Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
    J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
    Mazzone PJ; Silvestri GA; Patel S; Kanne JP; Kinsinger LS; Wiener RS; Soo Hoo G; Detterbeck FC
    Chest; 2018 Apr; 153(4):954-985. PubMed ID: 29374513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report.
    Mazzone PJ; Silvestri GA; Souter LH; Caverly TJ; Kanne JP; Katki HA; Wiener RS; Detterbeck FC
    Chest; 2021 Nov; 160(5):1959-1980. PubMed ID: 34270965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
    Mazzone PJ; Silvestri GA; Souter LH; Caverly TJ; Kanne JP; Katki HA; Wiener RS; Detterbeck FC
    Chest; 2021 Nov; 160(5):e427-e494. PubMed ID: 34270968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
    Chung JH; Richards JC; Koelsch TL; MacMahon H; Lynch DA
    AJR Am J Roentgenol; 2018 Mar; 210(3):503-513. PubMed ID: 29231759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.
    Tisi S; Creamer AW; Dickson J; Horst C; Quaife S; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Hacker AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; Hurst JR; ; Janes S
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37321665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental findings in low dose CT lung cancer screening of high-risk smokers: Results from the Manchester lung Health Check pilot.
    Bradley P; Bola BM; Balata H; Sharman A; Booton R; Crosbie PAJ
    Lung Cancer; 2022 Nov; 173():1-4. PubMed ID: 36099795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in a lung cancer screening program.
    Reiter MJ; Nemesure A; Madu E; Reagan L; Plank A
    Lung Cancer; 2018 Jun; 120():1-6. PubMed ID: 29748003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening.
    Morgan L; Choi H; Reid M; Khawaja A; Mazzone PJ
    Ann Am Thorac Soc; 2017 Sep; 14(9):1450-1456. PubMed ID: 28421812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.
    Humphrey LL; Deffebach M; Pappas M; Baumann C; Artis K; Mitchell JP; Zakher B; Fu R; Slatore CG
    Ann Intern Med; 2013 Sep; 159(6):411-420. PubMed ID: 23897166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.